Insider Transactions in Q2 2022 at Terns Pharmaceuticals, Inc. (TERN)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
May 31 2022	Senthil Vel Sundaram Chief Executive Officer	BUY Open market or private purchase	Direct	7,656 +50.0%	$7,656 $1.47 P/Share
May 31 2022	Mark J. Vignola Chief Financial Officer	BUY Open market or private purchase	Direct	7,656 +50.0%	$7,656 $1.47 P/Share
May 31 2022	Seokho Bryan Yoon COO and General Counsel	BUY Open market or private purchase	Direct	7,656 +50.0%	$7,656 $1.47 P/Share

Receive a notification when an Institution or Guru buys or sells TERN shares.

Notify only if

Value

Get notified when an Terns Pharmaceuticals, Inc. insider buys or sells TERN shares.

Notify only if

Operation

Value

Type

Receive news related to Terns Pharmaceuticals, Inc.